Alpha-blocker use is associated with decreased risk of sexual dysfunction.
OBJECTIVE
To examine the association between alpha-blocker use and sexual dysfunction among men participating in a population-based cohort of men residing in Olmsted County, MN. Lower urinary tract symptoms (LUTS) in men have previously been associated with sexual dysfunction. The use of alpha-adrenergic receptor blocking agents results in an improvement in LUTS for many men. If sexual dysfunction and LUTS share a common etiology, alpha-blocker use might also be associated with a decreased risk of sexual dysfunction.


METHODS
White men, aged 40-79 years, were randomly selected in 1990 and assessed for alpha-blocker use and LUTS severity. Sexual function was assessed using the Brief Male Sexual Function Inventory. Men who used alpha-blockers before any sexual dysfunction were considered "exposed." Hazard ratios and 95% confidence intervals were estimated separately for each sexual function domain using Cox proportional hazard models.


RESULTS
Of the 1724 men with a regular sexual partner included in the present study (mean age 57.74 years), 263 (15.3%) reported alpha-blocker use. alpha-Blocker use was associated with a decreased risk of sexual dysfunction across all domains for men > or =50 years old (age-adjusted hazard ratio 0.53-0.69). A decreased risk of erectile dysfunction and low libido remained significant only among those using alpha-blockers who also experienced an improvement in LUTS (P = .01).


CONCLUSIONS
The use of alpha-blockers for LUTS was associated with a decreased risk of sexual dysfunction. Improvement in sexual function correlated with the improvement in LUTS more strongly among those using alpha-blockers.
Kumar
Rajeev
R
Department of Urology, All India Institute of Medical Sciences, New Delhi, India.
Nehra
Ajay
A
Jacobson
Debra J
DJ
McGree
Michaela E
ME
Gades
Naomi M
NM
Lieber
Michael M
MM
Jacobsen
Steven J
SJ
St Sauver
Jennifer L
JL
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D053448:Prostatism / Q000150:complications* / Q000188:drug therapy*; D012307:Risk Factors; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy* / Q000209:etiology*
D000317:Adrenergic alpha-Antagonists